Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Designation crawled date : 2021 - 11 - 03 save search
European Medicines Agency Grants Orphan Drug Designation to Rafael Pharmaceuticals’ CPI-613® (Devimistat) for Treatment of Patients with Relapsed or Refractory Burkitt's Lymphoma
Published: 2021-11-03 (Crawled : 19:00) - globenewswire.com
RFL 4 | $1.72 0.59% 1.6K
|
Finance
|
| O: 8.55%
H: 10.91%
C: -3.03%
treatment orphan drug europe drug cpi-613 designation
Allena Pharmaceuticals Receives Fast Track Designation from FDA for the Development of ALLN-346 for Chronic Treatment of Hyperuricemia in Patients With Gout and Advanced Chronic Kidney Disease
Published: 2021-11-03 (Crawled : 12:15) - globenewswire.com
ALNA | $0.075 -12.0%
|
Health Technology
|
| O: 22.35%
H: 12.5%
C: -3.85%
disease treatment fda fast track fast track designation kidney designation
AVROBIO Receives Rare Pediatric Disease Designation from the U.S. FDA for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome
Published: 2021-11-03 (Crawled : 12:00) - biospace.com/
AVRO | $1.225 -1.21% 3.9K
|
Health Technology
|
| O: 2.99%
H: 0.0%
C: 0.0%
disease fda rare pediatric disease designation gene therapy therapy syndros designation rare avr-rd-05 rd-05 mps-ih
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.